Company Overview
About Humane Genomics
Humane Genomics is a synthetic virology biotech company engineering oncolytic viruses — synthetic RNA viruses designed to selectively infect and destroy cancer cells while leaving healthy cells unharmed — using a proprietary platform that programs viral behavior at the genomic level to create next-generation cancer therapies. The company raised $8.12 million in total funding including a February 2025 round led by Union Square Ventures with 14 investor participants, developing RNA-based viral cancer therapies for systemic delivery designed for extended therapeutic activity.
Business Model & Competitive Advantage
Humane Genomics' synthetic virology platform enables precise engineering of viral genomes to control which cell types the virus infects (cancer cell selectivity through tumor-specific entry mechanisms and replication-dependent killing), how long the virus remains active, and what payloads the virus carries (immune-stimulating transgenes that activate anti-tumor immune responses alongside direct viral killing). The synthetic approach, building viruses from scratch rather than modifying natural viruses, enables more precise control over safety and efficacy characteristics than naturally derived oncolytic virus platforms.
Competitive Landscape 2025–2026
In 2025, Humane Genomics competes in the oncolytic virus and cancer immunotherapy market with Genelux (GL-ONC1), Imvax, Replimune (REPL), and the broader cancer immunotherapy pipeline including checkpoint inhibitors and CAR-T for solid tumor oncology. Oncolytic virotherapy has seen renewed interest as the cancer immunotherapy field looks beyond checkpoint inhibitors (PD-1/PD-L1) for approaches that work in immunologically "cold" tumors that don't respond to immune checkpoint blockade. Union Square Ventures' lead investment reflects the growing biotech-focused investment activity at traditionally software-focused growth funds. The 2025 strategy focuses on preclinical validation of the synthetic virology platform, advancing lead programs toward IND-enabling studies, and building the manufacturing process for synthetic RNA virus production at clinical scale.
Recent Activity
View all →Quarterly Report filed 2026-05-12
Material Event filed 2026-05-12
Material Event filed 2026-05-01
IPO Prospectus filed 2026-04-30
IPO Registration filed 2026-04-27
Material Event filed 2026-04-27
Material Event filed 2026-04-27
Annual Report filed 2026-03-30
Material Event filed 2026-03-30
Key Differentiators
Emerging Innovator
Humane Genomics is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare Humane Genomics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Humane Genomics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Humane Genomics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Humane Genomics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →